Compare ACNT & APYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACNT | APYX |
|---|---|---|
| Founded | 1945 | 1982 |
| Country | United States | United States |
| Employees | 452 | N/A |
| Industry | Steel/Iron Ore | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 161.0M | 156.7M |
| IPO Year | 1995 | 1995 |
| Metric | ACNT | APYX |
|---|---|---|
| Price | $17.15 | $3.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 52.1K | ★ 104.5K |
| Earning Date | 01-01-0001 | 04-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 49.05 | 19.40 |
| EPS | ★ 0.20 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $22.72 | $9.36 |
| Revenue Next Year | N/A | $6.70 |
| P/E Ratio | $85.93 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $11.05 | $0.83 |
| 52 Week High | $17.92 | $4.50 |
| Indicator | ACNT | APYX |
|---|---|---|
| Relative Strength Index (RSI) | 57.60 | 34.81 |
| Support Level | $15.85 | $1.67 |
| Resistance Level | $17.92 | $4.40 |
| Average True Range (ATR) | 0.43 | 0.23 |
| MACD | -0.07 | -0.07 |
| Stochastic Oscillator | 42.87 | 3.26 |
Ascent Industries Co specializes in development, production, and distribution of specialty chemicals. The company produces specialty ingredients and products for the oil and gas, household, industrial and institutional, personal care, coatings, adhesive, sealants, elastomers, pulp and paper, textile, automotive, agricultural, water, treatment, and construction industries. The products of the company include: Surfactants, Defoamers, Flame Retardants, Emulsifiers, Lubricants, Plasticizers, Straight Esters and Others.
Apyx Medical Corp is an energy technology medical device company. It specializes in developing, manufacturing, and marketing a range of cosmetic and surgical products and technologies, as well as related medical products used in doctor's offices, surgery centers, and hospitals. Its product offerings comprise Renuvion cosmetic technology, which offers plastic surgeons, facial plastic surgeons, and cosmetic physicians the ability to provide controlled heat to the tissue to achieve desired results. The J-Plasma system allows surgeons to operate with a high level of precision and virtually eliminates unintended tissue trauma. It operates in two segments namely: Advanced Energy and Original Equipment Manufacturing (OEM). Its Advanced Energy segment derives the majority of its revenue.